HealthQuill Food allergy
An asthma drug, omalizumab, can “significantly” reduce the risk of allergic reactions caused by multiple foods among children and adults in case of accidental exposure, according to a study funded by the US medical research agency.
Drugs Health Pharma

Omalizumab or Xolair can lower risk of food allergies in kids, adults: NIH

HQ Team February 26, 2024: An asthma drug, omalizumab, can “significantly” reduce the risk of allergic reactions caused by multiple foods among children.

Read More
More than 131 million people in the Latin American and Caribbean population are not able to afford a healthy diet, due to high global food prices, according to a UN report.
Drugs Health Medical

Patient perceptions shed light on food allergy development: Study

HQ Team November 23, 2023: A recent survey conducted by Northwestern University reveals diverse perspectives among patients and caregivers regarding the development of.

Read More
X